Literature DB >> 18362921

Gene delivery to the nervous system.

Manfred Schubert1, Xandra Breakefield, Howard Federoff, Robert M Frederickson, Pedro R Lowenstein.   

Abstract

Mesh：

Year:  2008        PMID： 18362921      PMCID： PMC2630580          DOI： 10.1038/mt.2008.42

Source DB:  PubMed          Journal:  Mol Ther        ISSN： 1525-0016            Impact factor:   11.454


× No keyword cloud information.
  27 in total

1.  Safety of direct administration of AAV2(CU)hCLN2, a candidate treatment for the central nervous system manifestations of late infantile neuronal ceroid lipofuscinosis, to the brain of rats and nonhuman primates.

Authors:  Neil R Hackett; D Eugene Redmond; Dolan Sondhi; E Lela Giannaris; Elizabeth Vassallo; Jamie Stratton; Jianping Qiu; Stephen M Kaminsky; Martin L Lesser; Gene S Fisch; Serge D Rouselle; Ronald G Crystal
Journal:  Hum Gene Ther       Date:  2005-12       Impact factor: 5.695

Review 2.  Immune shaping and the development of Alzheimer's disease vaccines.

Authors:  Howard J Federoff; William J Bowers
Journal:  Sci Aging Knowledge Environ       Date:  2005-11-16

Review 3.  Gene therapy progress and prospects: hydrodynamic gene delivery.

Authors:  H Herweijer; J A Wolff
Journal:  Gene Ther       Date:  2006-11-30       Impact factor: 5.250

Review 4.  Lentiviral vectors for use in the central nervous system.

Authors:  Johan Jakobsson; Cecilia Lundberg
Journal:  Mol Ther       Date:  2006-01-03       Impact factor: 11.454

5.  Transduction of motor neurons and muscle fibers by intramuscular injection of HIV-1-based vectors pseudotyped with select rabies virus glycoproteins.

Authors:  George Z Mentis; Maneth Gravell; Rebecca Hamilton; Neil A Shneider; Michael J O'Donovan; Manfred Schubert
Journal:  J Neurosci Methods       Date:  2006-05-24       Impact factor: 2.390

6.  Long-term clinical improvement in MPTP-lesioned primates after gene therapy with AAV-hAADC.

Authors:  Krystof S Bankiewicz; John Forsayeth; Jamie L Eberling; Rosario Sanchez-Pernaute; Philip Pivirotto; John Bringas; Peter Herscovitch; Richard E Carson; William Eckelman; Bryan Reutter; Janet Cunningham
Journal:  Mol Ther       Date:  2006-07-07       Impact factor: 11.454

7.  Cyclophosphamide enhances glioma virotherapy by inhibiting innate immune responses.

Authors:  Giulia Fulci; Laura Breymann; Davide Gianni; Kazuhiko Kurozomi; Sarah S Rhee; Jianhua Yu; Balveen Kaur; David N Louis; Ralph Weissleder; Michael A Caligiuri; E Antonio Chiocca
Journal:  Proc Natl Acad Sci U S A       Date:  2006-08-14       Impact factor: 11.205

8.  Gene transfer in humans using a conditionally replicating lentiviral vector.

Authors:  Bruce L Levine; Laurent M Humeau; Jean Boyer; Rob-Roy MacGregor; Tessio Rebello; Xiaobin Lu; Gwendolyn K Binder; Vladimir Slepushkin; Franck Lemiale; John R Mascola; Frederic D Bushman; Boro Dropulic; Carl H June
Journal:  Proc Natl Acad Sci U S A       Date:  2006-11-07       Impact factor: 11.205

9.  Gene therapy of metachromatic leukodystrophy reverses neurological damage and deficits in mice.

Authors:  Alessandra Biffi; Alessia Capotondo; Stefania Fasano; Ubaldo del Carro; Sergio Marchesini; Hisaya Azuma; Maria Chiara Malaguti; Stefano Amadio; Riccardo Brambilla; Markus Grompe; Claudio Bordignon; Angelo Quattrini; Luigi Naldini
Journal:  J Clin Invest       Date:  2006-11       Impact factor: 14.808

10.  In vivo mature immunological synapses forming SMACs mediate clearance of virally infected astrocytes from the brain.

Authors:  Carlos Barcia; Clare E Thomas; James F Curtin; Gwendalyn D King; Kolja Wawrowsky; Marianela Candolfi; Wei-Dong Xiong; Chunyan Liu; Kurt Kroeger; Olivier Boyer; Jerzy Kupiec-Weglinski; David Klatzmann; Maria G Castro; Pedro R Lowenstein
Journal:  J Exp Med       Date:  2006-08-21       Impact factor: 14.307
View more
  4 in total

1.  Peptide-modified vectors for nucleic acid delivery to neurons.

Authors:  E J Kwon; J M Bergen; I K Park; S H Pun
Journal:  J Control Release       Date:  2008-06-21       Impact factor: 9.776

2.  Region-specific genetic alterations in the aging hippocampus: implications for cognitive aging.

Authors:  Corinna Burger
Journal:  Front Aging Neurosci       Date:  2010-10-14       Impact factor: 5.750

3.  Role of the H1 haplotype of microtubule-associated protein tau (MAPT) gene in Greek patients with Parkinson's disease.

Authors:  Nikolaos Refenes; Juliane Bolbrinker; Georgios Tagaris; Antonio Orlacchio; Nikolaos Drakoulis; Reinhold Kreutz
Journal:  BMC Neurol       Date:  2009-06-28       Impact factor: 2.474

4.  Translational neurophysiology in sheep: measuring sleep and neurological dysfunction in CLN5 Batten disease affected sheep.

Authors:  Nicholas Perentos; Amadeu Q Martins; Thomas C Watson; Ullrich Bartsch; Nadia L Mitchell; David N Palmer; Matthew W Jones; A Jennifer Morton
Journal:  Brain       Date:  2015-02-26       Impact factor: 13.501
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.